Veltassa

Active Ingredient(s): Patiromer
FDA Approved: * October 21, 2015
Pharm Company: * RELYPSA INC
Category: Potassium Levels

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Veltassa Overview

Patiromer (USAN, trade name Veltassa) is a drug used for the treatment of hyperkalemia (elevated blood potassium levels), a condition that may lead to palpitations and arrhythmia (irregular heartbeat). It works by binding potassium in the gut.[1][2] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4.1 Mechanism of action 4.2 Pharmacokinetics 5 Chemistry 6 History 6.1 Studies 6.2 Approval 7 See also 8 References Medical uses...

Read more Veltassa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Patiromer

Recent Veltassa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Patiromer
  • Powder: 16.8g, 16.8gm/packet, 25.2g, 25.2gm/packet, 8.4g, 8.4gm/packet
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Veltassa: (3 results)

Sorted by National Drug Code
  • 53436-084 Veltassa 8.4 g/1 Oral Powder, for Suspension by Relypsa, Inc.
  • 53436-168 Veltassa 16.8 g/1 Oral Powder, for Suspension by Relypsa, Inc.
  • 53436-252 Veltassa 25.2 g/1 Oral Powder, for Suspension by Relypsa, Inc.

Other drugs which contain Patiromer or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA